These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14756678)

  • 21. Sodium-induced cardiac hypertrophy. Cardiac sympathetic activity versus volume load.
    Fields NG; Yuan BX; Leenen FH
    Circ Res; 1991 Mar; 68(3):745-55. PubMed ID: 1835910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery.
    Chiba K; Moriyama S; Ishigai Y; Fukuzawa A; Irie K; Shibano T
    Br J Pharmacol; 1994 Jul; 112(3):837-42. PubMed ID: 7921610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma volume and arterial stiffness in the cardiac alterations associated with long-term high sodium feeding in rats.
    Cordaillat M; Reboul C; Gaillard V; Lartaud I; Jover B; Rugale C
    Am J Hypertens; 2011 Apr; 24(4):451-7. PubMed ID: 21233801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Right ventricular performance after monocrotaline-induced pulmonary hypertension.
    Werchan PM; Summer WR; Gerdes AM; McDonough KH
    Am J Physiol; 1989 May; 256(5 Pt 2):H1328-36. PubMed ID: 2524170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of 17-methoxyl-7-hydroxy-benzene-furanchalcone on the pressure overload-induced progression of cardiac hypertrophy to cardiac failure.
    Huang J; Tang X; Liang X; Wen Q; Zhang S; Xuan F; Jian J; Lin X; Huang R
    PLoS One; 2014; 9(3):e91834. PubMed ID: 24622486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pioglitazone attenuates cardiac fibrosis and hypertrophy in a rat model of diabetic nephropathy.
    Elrashidy RA; Asker ME; Mohamed HE
    J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):324-33. PubMed ID: 22261714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bradykinin (B2) independent effect of captopril on the development of pressure overload cardiac hypertrophy.
    Turcani M; Rupp H
    Mol Cell Biochem; 2000 Sep; 212(1-2):219-25. PubMed ID: 11108154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative serial echocardiographic analysis of cardiac structure and function in rats subjected to pressure or volume overload.
    Cantor EJ; Babick AP; Vasanji Z; Dhalla NS; Netticadan T
    J Mol Cell Cardiol; 2005 May; 38(5):777-86. PubMed ID: 15850571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resveratrol arrests and regresses the development of pressure overload- but not volume overload-induced cardiac hypertrophy in rats.
    Wojciechowski P; Juric D; Louis XL; Thandapilly SJ; Yu L; Taylor C; Netticadan T
    J Nutr; 2010 May; 140(5):962-8. PubMed ID: 20335634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial capillary diffusion capacity in rat hearts with cardiac hypertrophy due to pressure and volume overload.
    Wåhlander H; Haraldsson B; Friberg P
    Am J Physiol; 1993 Jul; 265(1 Pt 2):H61-8. PubMed ID: 8342665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inotropic response of the rat heart during development and regression of triiodothyronine-induced hypertrophy.
    Lortet S; Zimmer HG; Rossi A
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):707-12. PubMed ID: 2481184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism and implications of brown adipose tissue proliferation in rats and monkeys treated with the thiazolidinedione darglitazone, a potent peroxisome proliferator-activated receptor-gamma agonist.
    Aleo MD; Lundeen GR; Blackwell DK; Smith WM; Coleman GL; Stadnicki SW; Kluwe WM
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1173-82. PubMed ID: 12626651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of rat heart morphology and function in vivo in two models of cardiac hypertrophy by means of magnetic resonance imaging.
    Rudin M; Pedersen B; Umemura K; Zierhut W
    Basic Res Cardiol; 1991; 86(2):165-74. PubMed ID: 1831609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional myosin heavy chain expression in volume and pressure overload induced cardiac hypertrophy.
    Dool JS; Mak AS; Friberg P; Wahlander H; Hawrylechko A; Adams MA
    Acta Physiol Scand; 1995 Dec; 155(4):396-404. PubMed ID: 8719259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardioprotective effects of troglitazone in streptozotocin-induced diabetic rats.
    Shimabukuro M; Higa S; Shinzato T; Nagamine F; Komiya I; Takasu N
    Metabolism; 1996 Sep; 45(9):1168-73. PubMed ID: 8781306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compensated function in hypertrophied ventricles of Wistar Kyoto and spontaneously hypertensive rats.
    Tomanek RJ; Whitaker MT
    Cardiovasc Res; 1990 Mar; 24(3):204-9. PubMed ID: 2140712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tedisamil attenuates foetal transformation of myosin in the hypertrophied rat myocardium.
    Turcani M; Thormaehlen D; Rupp H
    Br J Pharmacol; 2004 Nov; 143(5):561-72. PubMed ID: 15466442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of cardiac hypertrophy and heart failure due to volume overload in the rat.
    Wang X; Ren B; Liu S; Sentex E; Tappia PS; Dhalla NS
    J Appl Physiol (1985); 2003 Feb; 94(2):752-63. PubMed ID: 12531914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left ventricular failure induced by myocardial infarction. I. Myocyte hypertrophy.
    Anversa P; Loud AV; Levicky V; Guideri G
    Am J Physiol; 1985 Jun; 248(6 Pt 2):H876-82. PubMed ID: 3159268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.